提高流感疫苗接种率的干预措施成本:一项系统综述
该系统综述检索2004年1月至2016年7月文献,纳入18篇文章描述29项医疗系统内组织或结构变革干预。一般人群中位项目成本为每入组者3.27美元、每额外接种者50.78美元;医护人员中位成本为每入组者8.09美元、每额外接种者125.24美元。基于有限证据,一般人群的质量改进干预对卫生系统可能节约成本或具成本效果。
要点
- 一般人群23项干预中位成本:每入组者3.27美元,每额外接种者50.78美元。
- 医护人员6项干预中位成本:每入组者8.09美元,每额外接种者125.24美元。
- 一般人群10项完整经济学评价中3项报告净成本节约。
核心结论
- 流感疫苗接种质量改进干预的每入组者成本与疫苗本身成本(每剂11.78-36.08美元)相近。
- 基于一般人群中有限的现有证据,质量改进干预对卫生系统可能节约成本或具成本效果。
研究设计与样本
- 系统综述检索MEDLINE、Econlit、Centre for Reviews & Dissemination、Greylit和Worldcat数据库,检索时间为2016年7月,覆盖2004年1月至2016年7月发表的论文。
- 纳入评估医疗系统内机构通过组织或结构变革鼓励流感疫苗接种的研究。
- 共2350条记录中18篇文章符合纳入标准,描述29项独特干预。
主要发现
- 大多数干预提高了疫苗接种率。
- 一般人群23项干预中,每入组者项目成本中位数为3.27美元(四分位距0.82-11.53美元),每额外接种者成本中位数为50.78美元(四分位距27.85-124.84美元)。
- 一般人群10项完整经济学评价中,3项报告净成本节约,4项报告每质量调整生命年成本低于50,000美元,3项报告每挽救生命成本低于60,000美元。
- 医护人员6项干预中,每入组者项目成本中位数为8.09美元(四分位距5.03-10.31美元),每额外接种者成本中位数为125.24美元(四分位距96.06-171.38美元),无完整经济学分析。
关键数值与推荐
- 每入组者项目成本和每额外接种者成本均排除疫苗成本,并标准化为2017年美元。
- 一般人群每入组者成本中位数3.27美元(四分位距0.82-11.53美元),每额外接种者成本中位数50.78美元(四分位距27.85-124.84美元)。
- 医护人员每入组者成本中位数8.09美元(四分位距5.03-10.31美元),每额外接种者成本中位数125.24美元(四分位距96.06-171.38美元)。
- 疫苗成本为每剂11.78-36.08美元。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Influenza vaccination rates remain below Healthy People 2020 goals. This project sought to systematically review economic evaluations of healthcare-based quality improvement interventions for improving influenza vaccination uptake among general populations and healthcare workers. EVIDENCE ACQUISITION: The databases MEDLINE, Econlit, Centre for Reviews & Dissemination, Greylit, and Worldcat were searched in July 2016 for papers published from January 2004 to July 2016. Eligible studies evaluated efforts by bodies within the healthcare system to encourage influenza vaccination by means of an organizational or structural change. For each study, program costs per enrollee and per additional enrollee vaccinated were derived (excluding vaccine costs, standardized to 2017 U.S. dollars). Complete economic evaluations were examined when available. EVIDENCE SYNTHESIS: Of 2,350 records, 18 articles were eligible and described 29 unique interventions. Most interventions improved vaccine uptake. Among 23 interventions in general populations, the median program cost was $3.27 (interquartile range, $0.82-$11.53) per enrollee and $50.78 (interquartile range, $27.85-$124.84) per additional enrollee vaccinated. Among ten complete economic evaluations in general populations, three studies reported net cost savings, four reported costs <$50,000 per quality-adjusted life year, and three reported costs <$60,000 per life saved. Among six interventions in healthcare workers, the median program cost was $8.09 (interquartile range, $5.03-$10.31) per worker enrolled and $125.24 (interquartile range, $96.06-$171.38) per additional worker vaccinated (there were no complete economic analyses). CONCLUSIONS: Quality improvement interventions for influenza vaccination involve per-enrollee costs that are similar to the cost of the vaccine itself ($11.78-$36.08/dose). Based on limited available evidence in general populations, quality improvement interventions may be cost saving to cost effective for the health system.
引用
- Anderson LJ, Shekelle P, Keeler E, et al. The Cost of Interventions to Increase Influenza Vaccination: A Systematic Review. Am J Prev Med. 2018. PMID: 29362167. doi:10.1016/j.amepre.2017.11.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。